MediPal Holdings Corporation (TYO:7459)
Japan
· Delayed Price · Currency is JPY 2,872.00
-65.00 (-2.21%)
At close: Mar 9, 2026
MediPal Holdings Revenue
MediPal Holdings had revenue of 1.01T JPY in the quarter ending December 31, 2025, with 3.22% growth. This brings the company's revenue in the last twelve months to 3.78T, up 3.42% year-over-year. In the fiscal year ending March 31, 2025, MediPal Holdings had annual revenue of 3.67T with 3.16% growth.
Revenue (ttm)
3,775.82B
Revenue Growth
+3.42%
P/S Ratio
0.16
Revenue / Employee
289.09M
Employees
13,061
Market Cap
587.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,671.33B | 112.60B | 3.16% |
| Mar 31, 2024 | 3,558.73B | 198.72B | 5.91% |
| Mar 31, 2023 | 3,360.01B | 69.09B | 2.10% |
| Mar 31, 2022 | 3,290.92B | 79.80B | 2.48% |
| Mar 31, 2021 | 3,211.13B | -41.95B | -1.29% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,257.94B |
| HOYA Corporation | 915.21B |
| Takeda Pharmaceutical Company | 4,464.58B |
| Otsuka Holdings | 2,468.89B |
| Sumitomo Pharma | 453.40B |
| Sugi Holdings | 993.53B |
| Santen Pharmaceutical | 287.99B |
| COSMOS Pharmaceutical | 1,042.63B |